Federal Register / Vol. 72, No. 186 / Wednesday, September 26, 2007 / Notices 54667 

Ethics, Suite 500, 1201 New York 

Avenue, NW., Washington, DC 20005–

3917; Telephone: 202–482–9300; TDD: 

202–208–9293; FAX: 202–482–9237. 

SUPPLEMENTARY INFORMATION: 5 U.S.C. 

4314(c) requires each agency to 

establish, in accordance with 

regulations prescribed by the Office of 

Personnel Management at 5 CFR part 

430, subpart C and § 430.310 thereof in 

particular, one or more Senior Executive 

Service performance review boards. As 

a small executive branch agency, OGE 

has just one board. In order to ensure an 

adequate level of staffing and to avoid 

a constant series of recusals, the 

designated members of OGE’s SES 

Performance Review Board are being 

drawn, as in the past, in large measure 

from the ranks of other agencies. The 

board shall review and evaluate the 

initial appraisal of each OGE senior 

executive’s performance by his or her 

supervisor, along with any 

recommendations in each instance to 

the appointing authority relative to the 

performance of the senior executive. 

This revised notice updates the 

membership of OGE’s SES Performance 

Review Board as it was most recently 

published at 72 FR 53773–53774 

(September 20, 2007), in order to reflect 

the appointment of one new member 

from another agency to replace a 

member from an agency who was not 

able to serve on OGE’s board this year. 

Approved: September 21, 2007. 

Robert I. Cusick, 

Director, Office of Government Ethics. 

The following officials have been 

appointed as regular members of the 

SES Performance Review Board of the 

Office of Government Ethics: 

Marilyn L. Glynn [Chair], General 

Counsel, Office of Government Ethics 

Daniel D. Dunning [Alternate Chair], 

Deputy Director for Administration 

and Information Management, Office 

of Government Ethics 

Daniel L. Koffsky, Special Counsel, 

Office of Legal Counsel, Department 

of Justice 

David Maggi, Chief, Ethics Law and 

Programs Division, Office of the 

Assistant General Counsel for 

Administration, Department of 

Commerce; and 

Robert A. Shapiro, Associate Solicitor 

for Legal Counsel, Department of 

Labor 

[FR Doc. E7–18973 Filed 9–25–07; 8:45 am] 

BILLING CODE 6345–02–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Centers for 

Disease Control and Prevention (CDC) 

Grants for Public Health Research 

Dissertation, Program Announcement 

(PA) PAR07–231, Panel B 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 8 a.m.–4 p.m., November 

15, 2007 (Closed). 

Place: Crowne Plaza Buckhead, 3377 

Peachtree Road, NE., Atlanta, GA 30326, 

telephone 404–264–1111. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘CDC Grants for Public Health 

Research Dissertation,’’ PA PAR07–231, 

Panel B. 

Contact Person for More Information: 

Susan B. Stanton, D.D.S., Scientific Review 

Administrator, Office of the Chief Science 

Officer, CDC, 1600 Clifton Road, NE., 

Mailstop D 72, Atlanta, GA 30333, Telephone 

404–639–4640. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 20, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–18945 Filed 9–25–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Centers for 

Disease Control and Prevention (CDC) 

Grants for Public Health Research 

Dissertation, Program Announcement 

(PA) PAR07–231, Panel C 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 8:30 a.m.–4 p.m., 

November 16, 2007 (Closed). 

Place: Crowne Plaza Buckhead, 3377 

Peachtree Road, NE., Atlanta, GA 30326, 

telephone 404–264–1111. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘CDC Grants for Public Health 

Research Dissertation,’’ PAR07–231, Panel C. 

Contact Person for More Information: 

Sheree Marshall Williams, Ph.D., M.Sc., 

Scientific Review Administrator, Office of 

the Chief Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D 72, Atlanta, GA 30333, 

Telephone 404–639–4896. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 20, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–18947 Filed 9–25–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the President’s Cancer 

Panel. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

mstockstill on PROD1PC66 with NOTICES

54668 Federal Register / Vol. 72, No. 186 / Wednesday, September 26, 2007 / Notices 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.s.C., as 

amended, because the premature 

disclosure of information and the 

discussions would likely to significantly 

frustrate implementation of 

recommendations. 

Name of Committee: President’s Cancer 

Panel. 

Date: October 22, 2007. 

Open: October 22, 2007, 8 a.m.–4 p.m. 

Agenda: Strategies for Maximizing the 

Nation’s Investment in Cancer. 

Place: Hyatt Regency La Jolla, 3777 La Jolla 

Village Drive, San Diego, CA 92122. 

Closed: October 22, 2007, 4:30 p.m.–6:30 

p.m. 

Agenda: The Panel will discuss potential 

recommendations from current series 

‘‘Strategies for Maximizing the Nation’s 

Investment in Cancer’’ and discuss potential 

topics for the 2008/2009 series. 

Place: Hyatt Regency La Jolla, 3777 La Jolla 

Village Drive, San Diego, CA 92122. 

Contact Person: Abby Sandler, Ph.D, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 

Building 6116, Room 212, 6116 Executive 

Boulevard, Bethesda, MD 20892, 301/451/ 

9399. 

Any interested person may file written 

comments with the committee by forwarding 

the comments to the Contact Person listed on 

this notice. The comments should include 

the name, address, telephone number and, 

when applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/pcp/pcp.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research, 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4739 Filed 9–25–07; 8:45am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

NIMH Brainbank Review. 

Date: October 15, 2007. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David M. Armstrong, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center/ 

Room 6138/MSC 9608, 6001 Executive 

Boulevard, Bethesda, MD 20892–9608, 301–

443–3534, armstrda@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, Adult 

DCISIR & ACISIR Centers. 

Date: November 13, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriot North Bethesda Convention 

Center, 5701 Marinelli Road, Bethesda, MD 

20852. 

Contact Person: Marina Broitman, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6153, MSC 9608, 

Bethesda, MD 20892–9608, 301–402–8152, 

mbroitma@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: September 18, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4737 Filed 9–25–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Disease; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, Rheumatic 

Disease Clinical Trial. 

Date: October 2, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy One, 6701 Democracy Boulevard, 

800, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Kan Ma, PhD, Scientific 

Review Administrator, NIH/NIAMS, EP 

Review Branch, One Democracy Plaza Suite 

800, Bethesda, MD 20892–4872, 301–594–

4952, mak2@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, 

Musculoskeletal Diseases Clinical Trial 

Planning Grants. 

Date: October 9, 2007. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Kan Ma, PhD, Scientific 

Review Administrator, NIH/NIAMS, EP 

Review Branch, One Democracy Plaza Suite 

mstockstill on PROD1PC66 with NOTICES